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ABSTRACT
A
pandemic of metabolic diseases (atherosclerosis,
diabetes mellitus, and obesity), unleashed by multiple
social and economic factors beyond the control of
most individuals, threatens to diminish human life span for
the ﬁrst time in the modern era. Given the redundancy and
inherent complexity of processes regulating the uptake,
transport, catabolism, and synthesis of nutrients, magic
bullets to target these diseases will be hard to ﬁnd. Recent
studies using the worm Caenorhabditis elegans, the ﬂy Drosophila
melanogaster, and the zebraﬁsh Danio rerio indicate that these
‘‘lower’’ metazoans possess unique attributes that should help
in identifying, investigating, and even validating new
pharmaceutical targets for these diseases. We summarize
ﬁndings in these organisms that shed light on highly
conserved pathways of energy homeostasis.
Introduction
Major shifts in human populations to urban centers,
engagement in sedentary employment and leisure activities,
and over-abundance of calorie-dense, processed foods have
created a milieu in which ancient metabolic pathways that
evolved under pressures to extract enough energy from the
environment to maintain optimal reproductive and immune
function and to tolerate short bouts of fasting, while avoiding
excessive weight gain that would hinder escape from would-
be predators, are running amuck [1]. The consequence of
excess stored energy, human obesity, is poised to negate the
tremendous improvements in sanitation, obstetric care, and
massive vaccination that marked the developed world in the
last century. For the ﬁrst time in the modern era, life
expectancy is expected to decrease [2]. Recognizing that it is
unlikely that the social and economic pressures that
generated our ‘‘toxic’’ lifestyle will be reversed, current
research in energy metabolism focuses on mitigating the
consequences of modernity. Increasingly sophisticated
approaches are required to understand the critical nodes of
energy homeostasis and to develop new drug targets.
The energy-producing, storing, and transferring reactions
of life are a common thermodynamic inheritance of all
organisms. The large catalog of in-born errors in human
metabolism includes a series of mutations ranging in
phenotype from mildly hypomorphic (e.g., 75% loss in
activity) to completely null (e.g., absence of activity) in the key
enzymes of cellular energetics that are shared by metazoans
(Figure 1). Although these mutations are rare in the general
population, elucidation of the genetic and biochemical
underpinnings of monoallelic diseases has greatly helped
focus research in more common diseases, in general [3], and
of energy metabolism, in particular. Several such disorders
have comparable syndromes in ‘‘lower’’ metazoans (Table 1).
As will be discussed below, unbiased methods have been used
to identify more genes whose mutation in lower metazoans
leads to phenotypes that are comparable to human
syndromes of altered energy homeostasis like obesity.
Since it is unlikely that the social and economic pressures
that have generated a global pandemic of obesity will be
reversed, creative tools are required to understand the
signaling pathways that govern energy homeostasis and to
develop new drug targets that exploit this new knowledge. In
this review, we highlight metabolic research in three
metazoan organisms, and argue that these studies are not
mere exercises in comparative energetics (Table 2). Rather,
studies on energy homeostasis in C. elegans, Drosophila, and
zebraﬁsh are proving that genetically tractable lower
organisms can alter our understanding of the relationship of
metabolic processes underlying obesity and its related
illnesses (atherosclerotic vascular disease and type 2 diabetes
mellitus). Through study of these organisms, insights relating
energy homeostasis to life span, reproduction, and immune
function have been made [4–7]. Below we focus on studies of
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are the main energy storage material and drug targets to
combat obesity will necessarily alter their metabolism.
Insulin/Insulin-Like Growth Factor Signaling,
Bridging Metabolic Control and Regulation of Life
Span, Reproduction, and Immune Function
The evolutionarily central insulin/insulin-like growth
factor signaling pathway (IIS) has been characterized in great
detail in Drosophila and C. elegans. Orthologous proteins for
nearly all of the intermediates in this cascade are found in
vertebrates. Multiple mutations in components of the IIS
pathway result in alterations in life span [8], have differential
effects on body size and fertility, and cause alterations in fat
accumulation in their major lipid storage organs [4–7]. A
consensus is emerging, however, that decreased adiposity,
achieved through genetic lesions in IIS in lower metazoan,
dietary restriction in rodents, and bariatric surgery in
humans, can prolong healthy life span [9–11].
C. elegans, Studying Whole-Organism Lipid Stores
One Gut Granule at a Time
In C. elegans adults, triacylglycerol (TAG) is stored in gut
granules (Figure 2), enterocyte lysosomes, whose genesis, size,
and trafﬁc are amenable to genetic study [12–15]. These
structures are not directly analogous to the lipid droplets
seen in the Drosophila fat body, or in vertebrate adipose tissue;
however, gut granule form and function is regulated by highly
conserved nutrient sensing and intracellular signaling
pathways.
Four novel genes were identiﬁed in a genetic screen for
mutations causing gut granule loss (glo mutants) by searching
for defects in the accumulation of ﬂuorescent dyes that label
acidiﬁed, mature lysosomes speciﬁcally [13]. GLO-1 is a novel
doi:10.1371/journal.pgen.0030199.g001
Figure 1. Machinery of Vertebrate Intestinal and Hepatic Lipid Transport
Lipid transport in the liver and intestine involves similar cellular machinery, although the direction of traffic of nutrients and wastes is directed
differentially. In the intestine, TAG, cholesterol esters (CE), and phospholipids (not shown) are hydrolyzed into FA and cholesterol by lipases (red) and
cholesteryl esterases (not shown) in the intestinal lumen. FAs are transported across the apical membrane of the enterocyte by FA transport proteins
(FATP, purple) and then activated with coenzyme A by acyl coenzyme A (AcSCoA) synthase (pink). AcSCoAs are used by various acyl transferases (not
shown) to build TAG and CE. In the lumen of the endoplasmic reticulum (ER), microsomal triacylglycerol transfer protein (MTP) and its obligate binding
partner protein disulfide isomerase (Pdi) combine neutral lipids with ApoB to make chylomicrons (blue). Chylomicrons are secreted across the
basolateral membrane. Orlistat inhibits TAG hydrolysis [85] and ezetimibe blocks cholesterol uptake (red arrows) [86]. Alpha lipoproteins (high density
lipoprotein particles, HDL) are also secreted by the intestine in small amounts, but the major site of synthesis is the liver. The liver retrieves free FAs from
the circulation through basolateral FA transport proteins on the surface of hepatocytes; beta lipoprotein particles are retrieved by receptor mediated
endocytosis on this surface as well by the low density lipoprotein particle receptor (LDL-R). Retrieved FAs are either subjected to beta oxidation in
mitochondria, or reincorporation in TAG. Either cholesterol is esterified to FAs, repackaged into nascent VLDL, or subjected to hydroxylation and
subsequent secretion into the bile. De novo synthesis of cholesterol and FAs also occurs in the hepatocyte, a process regulated by sterol regulatory
element binding proteins and various nuclear receptors (not shown). Familial hypercholesterolemia is due to defects in LDL-R. Abetalipoproteinemia is
due to mutations in MTP. Hypobetalipoproteinemia is due to mutations in Apob.
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PLoS Genetics | www.plosgenetics.org November 2007 | Volume 3 | Issue 11 | e199 2040Rab GTPase that associates with gut granules and is required
for intestinal lysosome acidiﬁcation. GLO-4 is a potential
guanine nucleotide exchange factor that may activate GLO-1
by exchanging GDP for GTP (Figure 2). Whether the
remaining glo mutants have altered neutral lipid stores,
altered fertility, or changes in life span as a consequence of a
defect in gut granule genesis are open questions. Likewise,
the involvement of these proteins in higher metazoan neutral
lipid homeostasis should be investigated.
RNAi: Reverse genetics for system validation and
comprehensive surveys. The transcription factors C/EBP and
steroid regulatory element binding protein 1 (SREBP-1) are
necessary and sufﬁcient for mammalian adipogenesis in vitro.
RNAi-mediated depletion of C/EBP and SREBP-1 led to lipid
depletion (lpd mutants) of C. elegans gut granules. [16]. Known
target genes of SREBP and C/EBP, including the genes
encoding enzymes of de novo fatty acid (FA) synthesis (e.g.,
acetyl co-A carboxylase, fatty acid synthase), were
downregulated in animals depleted of these transcription
factors. A secondary screen using a library of 80 RNAi vectors
known to cause larval arrest (RNAi of C/EBP or SREBP-1
causes larval arrest) uncovered eight more proteins whose
knockdown caused the lpd phenotype. Three of these lpd
genes encode proteins that are components of the
mitochondrial respiratory chain, suggesting an obvious cause
(decreased beta oxidation) for the lpd phenotype [16]. LPD-3
is a novel protein of unknown function whose depletion
caused decreased gut granule lipid accumulation. The lpd-3
gene is expressed in worm intestine and mammalian adipose
tissue. A short-hairpin RNA strategy to knock down LPD-3 in
3T3-L1 preadipocytes caused decreased lipid accumulation,
indicating the conserved function of this protein [16].
In a comprehensive RNAi survey, depletion of 305 proteins
led to decreased intestinal lipid stores, while depletion of 112
proteins led to increased intestinal lipid stores [17]. Most
proteins in both pools have mammalian orthologs, and the
observed phenotypes were biologically plausible in most
cases: many proteins known to be involved in energy
homeostasis were identiﬁed. This tractable list of genes
should guide not only future studies in C. elegans, but should
also prioritize human and rodent investigations. For example,
PGP-2 (glo-5), an ABC family transporter identiﬁed in this
screen, was subsequently found to be required for gut granule
acidiﬁcation [13–15]. Like GLO-1 and GLO-4, PGP-29s
identiﬁcation links gut granule biogenesis to neutral lipid
storage (Figure 1). Whether mutation of PGP-2 affects
transport of lipids or sterols into the nascent gut granule is
Table 2. Some Parallels and Differences among Model Organisms and Human Metabolism, as Compared by Organ System
H. sapiens and M. musculus C. elegans D. melanogaster D. rerio
Central and peripheral nervous system
regulation of metabolism; autonomic
and hormonal modulation of acute
energy needs.
Multiple studies identifying specific
neuronal populations’ involvement
in regulating feeding behavior and
gut granule lipid mass. A
hypothalamus-like structure is
not present.
Several hormone-producing areas
within the brain have been
implicated in regulating energy
metabolism.
The vertebrate brain, cranial nerves,
and peripheral nervous systems
are robust in this animal.
Development and function of the
hypothalamus and pituitary gland
are active areas of investigation.
Pituitary hormone target-organs
including thyroid gland, adrenal
(intrarenal) gland, and gonads
are present.
Endocrine pancreas production of
insulin and glucagon regulate
sugar and lipid metabolism.
There is no orthologous structure.
Mutations in multiple components of
insulin signaling affect gut granule
lipid mass, life span, and
reproduction.
Insulin-like proteins, and the
counter-regulatory adipokinetic
hormone perform similar functions
to human proteins, but are
produced in physically separate
parts of the brain. Glucose is not
the principle carbohydrate
in hemolymph.
Well-characterized endocrine
pancreas present and functional by
the late larval stage [114].
Liver and intestinal integration of
glucose and lipid metabolism;
lipoprotein production and
transport.
Intestinal cells and skeletal muscle
perform nutrient storage functions.
No liver-like structure is present.
Oenocytes function as hepatocytes
in converting fat body derived FAs into
ketone bodies during fasting.
Lipoprotein particles produced using
highly conserved microsomal triglyceride
transfer protein and vitellogenins are
present in the gonad. Fat body-derived
DAG is transported in high-density
lipophorin particles [87,100].
Conventional vertebrate body plan
is present. The liver and intestine
use microsomal triglyceride transfer
protein to produce beta lipoprotein
particles. Vitellogenins and lipovitellins
are present in the maternally supplied
yolk, and in female adults producing
eggs after spawning. Dietary and
liver-derived lipids are probably supplied
to other tissues using apolipoprotein B.
Adipose tissue storage of neutral
lipids. Production of hormones.
Neutral lipids are stored in intestinal
epithelium gut granules, lysosome-
like structures. Gut granule lipid mass
is regulated by many genes known to
be involved in adipocyte biology. Life
span and fertility affected by gut
granule lipid mass and insulin
signaling.
Larval and adult fat body cells store
neutral lipids, respond to and produce
hormones based on food supply. Fat
mass sensed by brain and integrated
into regulation of life span and
reproduction. Human and mouse
adipogenesis program employs similar
gene networks as fat body.
In late larval and early juvenile stages,
mesoderm-derived adipose tissue is
seen [115]. Regulation of adipose mass
and hormone production have not been
characterized extensively.
doi:10.1371/journal.pgen.0030199.t002
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mutations that suppress the glo phenotype.
What does Tubby do?
The spontaneously obese Tubby mouse has a mutation in a
gene of unknown function. Mouse Tub is expressed in the
central nervous system, and there is evidence that it is a
transcription factor [18,19], an adaptor molecule involved in
insulin receptor signaling [20], or a regulator of vesicular
transport [21]. A worm tub-1 mutant showed a modest
decrease in gut granule lipid accumulation. Five alleles of a 3-
ketoacyl-coA thiolase gene, kat-1 were identiﬁed in a screen
for mutations that could suppress the tub-1 mutant
phenotype [22]. KAT-1 may be localized to mitochondria or
peroxisomes in a dynamic manner and may be required for
FA oxidation. Since KAT-1 is expressed in muscles and
enterocytes, it was surprising that the tub-1 mutant phenotype
was rescued through either restoring normal KAT-1
expression in muscle and intestine, or in intestine alone.
Restoring KAT-1 expression in muscle alone did not affect
the increased lipid mass in the intestine. Mutations causing
alterations in ciliated neurogenesis recapitulated the genetic
interaction of tub-1 and kat-1, suggesting that a
neurohormonal mechanism regulates intestinal lipid stores
[22]. Finally, tub-1 regulation of fat stores is not regulated by
the insulin receptor ortholog daf-2, nor does it require the
downstream forkhead family transcription factor daf-16. Both
daf-2 and daf-16 regulate life span in addition to lipid
metabolism [23,24], indicating that tub-1 can selectively
modulate lipid metabolism without impacting longevity [25].
TUB-1 interacts with a Rab GTPase activating protein
RBG-3 in ciliated neurons where TUB-1 undergoes both
dendritic and ciliary transport, suggesting that TUB-19s
function in the worm is to modulate chemosensory or
neurohormonal functions [25]. Given the role of serotonergic
neurons in regulating feeding behavior and regulating lipid
stores in the worm [26], it shall be important to determine if
TUB-1 modulates serotonergic neuron function, and whether
the underlying signaling pathways between these neurons and
the periphery communicate with those regulating longevity
[27,28].
Nutrient sensing: Coordinating a global response to fasting.
In response to a 1-h fast of adult worms, the abundance of 18
of 97 mRNAs encoding genes involved in glucose and lipid
metabolism examined by reverse transcriptase polymerase
chain reaction is modulated [29]. Induced ‘‘fasting response’’
genes include those involved in mobilization of fat stores for
energy production, while some mitochondrial beta oxidation
genes are repressed. Four FA desaturases are induced, while
one (stearoyl-coA desaturase, SCD) is repressed strongly. This
differential gene expression leads to global changes in FA
composition [29]. Expression of nhr-49, which encodes a
nuclear (hormone) receptor required for induction of beta
oxidation, is also upregulated. Conversely, deletion of nhr-49
results in elevated fat content and shortened life span. NHR-
49 regulation of life span is dependent on SCD, but NHR-49
regulation of beta oxidation was independent of SCD [30].
This observation raises the possibility that SCD activity is
required not for short-term catabolism, but for generation of
lipid signaling molecules that have long-term effects [31]. The
functions of the Drosophila, zebraﬁsh, mouse, and human
orthologs of NHR-49 are summarized in Table 1.
Drosophila, a Fat Body for the Ages
The Drosophila fat body is a structure that stores maternally
supplied lipids, and ‘‘feeds’’ the developing animal during its
larval stages. As these lipid stores are consumed, most of the
fat body cells die [32], although a few dissociated cells persist
into adulthood, and are required to supply the animal with
energy prior to the onset of feeding [33]. Adult males also
require these remnant cells for proper mating behavior,
suggesting that they are involved in hormone production [34].
Genetic manipulation of insulin signaling has the most
doi:10.1371/journal.pgen.0030199.g002
Figure 2. C. elegans Lipid Storage
(A) C. elegans lipid stores are found in gut granules, intestinal cell lysosomes that can be visualized with polarized microscopy, and labeled for neutral
lipids with fluorescent dyes like nile red (red circles). Following feeding, greater lipid mass can be appreciated by the increased number and size of lipid-
laden gut granules. To identify proteins involved in regulating the amount of lipids stored in gut granules, a reverse genetic screen can be performed.
Depletion of individual proteins using an RNAi library may cause increases or decreases in lipid mass.
(B) Higher magnification view of the boxed region in (A) (bottom) showing the proteins involved in gut granule biogenesis and lipid accumulation.
Acidification of nascent gut granules by the proton pump PGP-2 (dark blue) precedes lipid accumulation. Intracellular trafficking of nascent gut
granules is governed by the GTPase encoded by glo-1 (black) and its guanine nucleotide exchange factor, encoded by glo-4 (light blue). The lpd-3 gene
may regulate biogenesis (dashed circle) of gut granules, be required for the accumulation of lipids nascent gut granules, or it may contribute to both
processes.
PLoS Genetics | www.plosgenetics.org November 2007 | Volume 3 | Issue 11 | e199 2042dramatic effect on lipid mobilization from the fat body, with
loss of insulin signaling leading to poor growth, runtiness,
infertility, and longevity in certain cases [5].
Many of the associations among various aspects of
physiology and Drosophila fat mass were made over four
decades ago with the female sterility(2)adipose mutant (adipose,
adp), a spontaneous mutant found to have increased fat body
size and female infertility [35,36]. Adp mutants are also
protected from starvation-induced death owing to this
increased and ‘‘available’’ energy storage pool [37]. The adp
gene encodes a WD40/tetratricopeptide-repeat-domain
protein [38] whose function in regulating TAG accumulation
is conserved in worms and mice as assessed through RNAi in
the former, and by exhaustive transgenesis and knockout
strategies in the latter [39]. The Adp protein regulates TAG
accumulation in fat body cells by modulating chromatin
acetylation and modulating PPARc activity [39]. In light of
this deﬁnitive study, the human ortholog WDTC1 is a
candidate gene for obesity worth pursuing.
Adipocytes are mesodermal cells generated by well
characterized transcriptional networks [40,41]. The
Hedgehog (Hh) morphogens, a group of cholesterol-modiﬁed
proteins involved in multiple developmental processes [42],
inhibit Drosophila fat body development and lipid
accumulation [43]. Treatment of mice with neutralizing anti-
Sonic Hh antibodies resulted in increases in adipose and total
body weight [44]. Speciﬁc inhibition of Hh signaling in adult
mesodermal stem or progenitor cells might be useful
treatments for lipodystrophies, rare acquired and inherited
diseases marked by adipose tissue loss and TAG
redistribution [45]. Conversely, speciﬁc activation of Hh
signaling could be useful for treatment of obesity.
Fat body regulation by an insulin signaling network.
Drosophila has cell types reminiscent of vertebrate metabolic
organs that regulate fat body lipid stores (Table 2): endocrine
pancreas-like cells and hepatocyte-like cells are found in
Drosophila. Their contributions to regulating adipose and
integration into other aspects of life are being appreciated
(Figure 3). Ablation of the insulin producing cells (IPCs) in
the brain of Drosophila causes developmental delay, runtiness,
elevated carbohydrate levels in larval hemolymph, and
increase lipid stores [46,47].
In insects, insulin function is ‘‘counter-regulated’’ by
adipokinetic hormone (AKH), a neuropeptide that functions
like glucagon and b-adrenergic agonists do in vertebrates in
counteracting insulin action. AKH is particularly important
for mobilizing energy stores for active ﬂight muscles [48,49],
when lipid droplet TAG stores are partially hydrolyzed into
diacylglycerol (DAG) and incorporated into lipoprotein
particles that deliver fuel to active muscles (Figure 3). AKH is
produced by the corpora cardia (CC) cells in another part of
the brain called the ring gland that is physically separate from
the IPCs [50]. AKH secretion is under control of the same
ATP-sensing apparatus used by vertebrate pancreatic b cells
to control insulin release [51], suggesting conservation of
function, if not form, among animals.
Lipid droplet dynamics. Study of lipid droplets in
Drosophila fat body cells have shown that the proteins coating
these storage structures are similar to those in mouse adipose
tissue in form and function [52]. The Drosophila PAT
(Perilipin, Adipophilin, and Tip47) family lipid droplet coat
protein lipid storage droplet-2 (Lsd-2) is expressed in the
ovary and the fat body [53,54]. Mutation of lsd-2 results in
defects in oogenesis [54], decreased fat body TAG
accumulation, and shortened life span [53]. These defects in
lipid storage and handling reﬂect perturbations in lipid
droplet motion within cells expressing mutated Lsd-2 [55].
Dynamic phosphorylation of Lsd-2 [55] and multiple other
proteins in the lipid droplet sub-proteome occurs during
intracellular trafﬁcking of these highly mobile energy storage
depots [56].
doi:10.1371/journal.pgen.0030199.g003
Figure 3. Drosophila Metabolic Integration and Lipoprotein Transport
In the fed state, IPCs release insulin. In the fat body, insulin promotes
nutrient storage. In the fasted state, AKH is released from the CC cells.
AKH promotes release of FAs from the fat body. FAs are retrieved by
oenocytes in the fasted state where they are stored as triacylglycerol in
lipid droplets (red circles) and metabolized to generate ketone bodies.
These metabolites are then released into the circulation for use as fuel
until the next feeding. The parallel cells and tissues in vertebrates are
shown in parentheses, although their physical arrangement is different
(e.g., vertebrate a and b cells reside in pancreatic islet of Langerhans).
Also, AKH and glucagon show no structural similarity, despite their
related function.
(B) During flight, Drosophila neutral lipid stored as TAG is partially
hydrolyzed into DAG in a process regulated by adipokinetic hormone
(not shown). This lipid mobilization may involve lipid storage droplet
proteins (LSD), the Brummer lipase (Bmm), and microsomal triglyceride
transfer protein (Mtp). Liberated DAGs combine with high density
lipophorin particles (HDLp), which have the coat proteins apolipophorins
I and II (stylized as a black curve on the surface of the blue sphere), to
make low density lipophorin particles (LDLp) when combined with
apolipophorin III (green). This LDLp particle delivers DAGs to active
skeletal muscles, which extract DAG from LDLp. Myocytes hydrolyze the
delivered DAG molecules into FAs. Beta oxidation generates the energy
required to sustain flight [87]. Also, lipids are delivered to insect fat body
cells by HDLp, which is bound to an insect lipophorin receptor (iLR) that
is internalized [88], but unlike endocytosed vertebrate LDL, insect HDLp
is not degraded. Rather, HDLp is recycled to the hemolymph after lipids
are extracted from the lipoprotein particle [89].
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multiple lipid droplet proteins, Lsd-2 chief among them,
show increased phosphorylation. Furthermore, lipid droplet
protein phosphorylation in response to AKH requires cyclic
AMP and protein kinase A, reminiscent of b-adrenergic
stimulation of mammalian lipolysis [57]. Conversely,
mutation of the adipokinetic hormone receptor gene
(AKHR), or ablation of AKH-producing CC cells leads to
increased fat body TAG stores, and to an inability to release
FAs from depot in response to starvation. This defect in fat
body lipolysis in animals lacking AKH signaling is manifested
by their earlier death when food is withdrawn [58].
The similarity between mammalian and Drosophila TAG
mobilization is underscored by observations involving the
brummer (bmm) mutant ﬂy and human neutral lipid storage
disease: both are caused by mutations in the gene encoding
adipocyte TAG lipase (ATGL, PNPLA2) [58,59]. Humans with
mutated ATGL experience neutral lipid droplet
accumulation in many organs, leading to widespread
impairment of normal function. Similarly, Atgl
 /  mice have
massive intracellular liposis in many tissues, including the
heart [60]. In bmm mutant ﬂies, increased TAG stores, frank
obesity, and an increased sensitivity to starvation (i.e., earlier
death) are seen. This ﬁnal phenotype contrasts with that seen
when adp mutant ﬂies are fasted, indicating that expanded
lipid mass does not necessarily mean increased availability of
calories during fasting [38]. The bmm mutant phenotype can
be antagonized by introducing an lsd-2 loss of function
mutation; bmm/lsd2 double mutants have normalized TAG
stores [61]. Mobilization of fat body TAG stores is under
hormonal regulation and may require lipases other than
Bmm: AKHR/bmm double mutants have higher fat body TAG
stores than either AKHR or bmm individual mutants, and are
more sensitive to starvation than either mutant [58].
The oenocyte: A proto-hepatocyte. During fasting,
mobilized adipose TAG stores are sent to the liver as free FAs
for partial oxidation to ketone bodies, molecules that can be
used by nearly all cell types as energy sources (Figure 3). The
Drosophila oenocyte functions in the capacity of ketogenic
hepatocyte during a fasting response [62]. Whereas eonocytes
show little lipid stores in the fed state, knockdown of the Slif
amino acid channel in fat body cells, a manipulation that
prompts protein catabolism and mobilization of amino acids
for ketogenesis in the ‘‘liver,’’ results in oenocyte lipid
accumulation. Similarly, knockdown of fat body cell lsd-2
decreases oenocyte lipid staining during starvation.
Conversely, overexpression of Brummer lipase in fat body
cells promotes oenocyte lipid accumulation during fasting.
Taken together, these ﬁndings suggest that oenocyte lipid
stores are derived from fat body cells, much like vertebrate
hepatocytes’ lipids are derived from TAGs that are mobilized
from adipocytes during fasting. Finally, targeted ablation of
oenocytes leads to runtiness and failure to mobilize fat body
lipid stores during fasting, a process that requires the lipid x-
hydroxylase Cyp4g1 [62].
Zebrafish: Vertebrate Metabolism Comes into
Genetic Focus
As a vertebrate, zebraﬁsh possesses many structural
similarities with humans that Drosophila and C. elegans do not
(Table 2). For instance, zebraﬁsh digestive organs, adipose
tissues, and skeletal muscle are physically arranged in a
manner similar to their human counterparts (Figure 4). Since
zebraﬁsh eggs are fertilized externally, the development and
onset of their metabolic activity can be monitored in real
time in live organisms.
Probing the machinery of lipoprotein transport. The
machinery of lipid synthesis and transport used by humans is
present and active in zebraﬁsh (Figure 1). Beta lipoproteins
are central to the trafﬁcking of yolk-supplied, intestinal, and
hepatic lipids. Like Drosophila, zebraﬁsh have several members
of this family, including the yolk lipoproteins (e.g.,
vitellogenin), and the hepatic and intestinal protein
apolipoprotein B (Apob). The packaging of lipids into beta
lipoprotein particles is the task of the evolutionary
progenitor of this family of proteins, microsomal triglyceride
transfer protein (Mtp), which is also present in the zebraﬁsh
yolk cell layer, intestine, and liver [63]. Knockdown of
zebraﬁsh Mtp expression using anti-sense morpholino
oligonucleotides (MOs) results in many of the phenotypes
seen in severe, lethal human abetalipoproteinemia and in
Mtp
 /  mice, with failure to transport yolk lipids and die in
utero by starvation [64].
While knockdown of zebraﬁsh Mtp recapitulates many of
doi:10.1371/journal.pgen.0030199.g004
Figure 4. Zebrafish Larval Anatomy and Detection of Mutations in Lipid
Homeostasis
(A) Zebrafish embryos and larvae subsist on yolk lipids for the first 4 d of
life.
(B) By 7 d post-fertilization, only the surfactant-filled swim bladder
(lavender) stains faintly with Oil Red O. The liver, pancreas (green),
intestine, and heart are visible through the skin at this stage of
development. The skeletal muscles (chevron-shaped somites) occupy the
posterior of the animal.
(C) Mutations causing inappropriate lipid accumulation in the liver
(upper), skeletal and cardiac muscles (middle), and vasculature (bottom)
can be easily visualized.
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Mtp
 /  mice, including death by failure to transport neutral
lipids across the yolk cell layer, an intermediate phenotype of
decreased, but not absent, vascular lipid staining was not seen
in Mtp MO-injected zebraﬁsh larvae. This ‘‘intermediate’’
phenotype is present in Mtp
þ/  mice and many humans with
point mutations in the orthologous MTTP gene [64]. This
distinction is important because there is heterogeneity in the
clinical phenotype of abetalipoproteinemia, ranging from
‘‘silent’’ low levels of serum cholesterol to severe
malabsorption of dietary lipids and fat-soluble vitamins.
Furthermore, whole organismal Apob levels were not affected
by Mtp knockdown, but we could not assess serum Apob
levels. These limitations indicate that advances in
methodology and ﬂexibility in using complementary systems
to follow up on ﬁndings in zebraﬁsh lipid metabolism will be
needed. Likewise, care must be taken in interpreting studies
that rely solely on targeted knockdown of proteins in this
model system.
Unlike C. elegans, which has comprehensive RNAi libraries
for transient knockdown of most genes, a large pool of
validated MOs is not available for systematic knockdown of
zebraﬁsh genes. One study illustrates this limitation.
Following a proteomic survey to identify cotranslationally
translocated (membrane and secretory) proteins in zebraﬁsh
embryos, a tractable set (150) of the corresponding genes was
selected for targeted knockdown with antisense MOs [65].
Knockdown of only one of these proteins, apolipoprotein C2
(Apoc2), affected transport of a ﬂuorescently tagged 12-
carbon FA injected into the yolk. Whether other MOs used in
this study simply failed to decrease protein expression is
unclear, but a likely reason for this ﬁnding is that the
maternal supply of the complement of cotranslationally
translocated proteins required for yolk lipid transport may
be sufﬁciently large that knockdown of any one component
will not affect lipid transport.
Analogous redundancy and compensation for loss of one of
three D9 FA desaturases occurs in worms [66], where
individual mutations of the corresponding genes leads to
minimal phenotypic difference. When the three possible
pairs of D9 FA desaturase mutants are examined, differential
effects on lipid stores are apparent, indicating subtle
differences in function [67]. Adding to the complexity of this
metabolic pathway, the expression of the three D9F A
desaturases is differentially regulated by NHR-49 [30], raising
the tempting possibility that these enzymes have unique
substrates and differ in their capacities to generate lipid
signaling molecules. As more robust MO libraries are
generated, targeted knockdown in zebraﬁsh may approach
this level of genetic sophistication.
The gonzo mutant also demonstrates the high degree of
conservation of metabolic regulatory function across animal
phyla: the affected gene encodes the site 1 protease
responsible for processing the ER membrane-tethered
transcription factor SREBP, the master regulator of de novo
cholesterol and FA synthesis [68]. gonzo mutants are incapable
of responding to low cellular cholesterol by activating SREBP,
and are thus genetically ‘‘starved’’ of lipids. This defect is
manifested by an inability to mobilize the yolk lipid stores, a
phenotype that is readily apparent with conventional staining
methods.
In addition to conﬁrming the conservation of known genes
in regulating lipid metabolism, zebraﬁsh has been useful in
identifying novel proteins involved in energy homeostasis.
The fat-free mutant fails to concentrate a ﬂuorescent FA
analog in its gall bladder [69]; the affected gene encodes a
novel component of the vesicular transport machinery [70].
While fat-free mutants appeared morphologically normal (and
would have been missed in the ﬁrst, large scale screens for
intestinal morphology), they have multiple defects in
intracellular transport. Since a large-scale genetic screen in
medaka has found three more mutants with defective
hepatobiliary processing of the same ﬂuorescent substrate
used to identify fat-free, further insights into these processes
are expected from genetic studies with ﬁsh [71].
Non-alcoholic fatty liver disease: Modeling complex human
metabolic diseases. One obesity-related disease receiving
increasing attention is non-alcoholic fatty liver disease
(NAFLD). The initial step in the pathogenesis of NAFLD is
the accumulation of excess neutral lipid in the liver, a
condition commonly seen in overweight and insulin-resistant
persons [72]. Two mutations from a library of mutations in
essential genes show hepatic steatosis [73]. Whether these
mutations are due to excessive de novo hepatic lipid
production, decreased hepatic secretion of very low density
lipoprotein particles, diminished beta oxidation of FAs in the
liver, more subtle defects in regulating energy homeostasis
including insulin resistance, or some non-cell-autonomous
cause is unknown. We await future studies of these two genes,
particularly of foie gras, whose encoded protein exhibits no
obvious domains and represents a completely novel pathway
to inappropriate accumulation of lipids in the liver.
Conclusions
To address the looming public health crisis of obesity and
its related illnesses, increasing attention is being turned to
the three work-horse organisms of modern genetics outlined
in this review. Future work with these organisms must exploit
their individual strengths and avoid their limitations (Table
2). In this section we outline the advances in metabolic
research we expect to be made in the near term in each
organism.
In C. elegans, integration of acute and long-term signals
among the nervous system, skeletal muscles, and intestine
should emerge from studies of gut granule biogenesis, ciliated
neurogenesis, and feeding behavior. These studies will
parallel and inform discoveries into the mechanisms by which
life span and fertility are regulated.
The accelerated pace of advances in studying the molecular
genetics of energy homeostasis in fruit ﬂies should allow
investigators to ask increasingly sophisticated questions
about physiology. In particular, understanding the signals
emanating from the fat body to the IPCs, CC cells, and
oenocytes should be informative. Further genetic dissection
of the regulation of Brummer lipase, particularly through
interaction with PAT proteins, should tell us more about how
lipid droplets are regulated. Finally, through exploration of
the form and function of the proto-pancreatic and hepatic
organs, we can expect new insights into the integration of
energy homeostasis and other facets of life including
reproduction, life span, and immune function.
Future screens of energy metabolism in zebraﬁsh must
harness the optical transparency and power of transgenesis to
PLoS Genetics | www.plosgenetics.org November 2007 | Volume 3 | Issue 11 | e199 2045label individual cells with ﬂuorescent protein to monitor real-
time changes in energy state [74]. Examination of the effects
of targeted cell ablation of pancreatic b cells should be
informative [75]. Mesodermal differentiation into adipose
tissue is also an exciting area amenable to study in zebraﬁsh
[76]. More generally, improvements in reverse genetic
strategies, including robotic systems for injection of antisense
MOs [77], and photoactivation of knock-down reagents to
allow for spatial and temporal control of knockdown, should
be adopted [78,79].
Broader questions of central nervous system regulation of
energy homeostasis could also be addressed in zebraﬁsh.
Vertebrate hypothalamic [80] and pituitary development [81]
are active areas of investigation, and further reﬁnements in
our understanding of how these structures are formed can be
expected. Genetic screens to identify mutations modulating
the activity of the neurohormonal circuits governing adipose
mass, the ‘‘adipostat,’’ are awaited also [82].
Ultimately, technical advances and more detailed
characterization of the known pathways regulating lower
metazoan energy metabolism should aid in identifying and
characterizing novel candidate genes for human diseases such
as obesity, diabetes mellitus, lipodystrophy, and non-alcoholic
fatty liver disease. Conversely, the function of completely
novel genes implicated in obesity [83] and diabetes [84] may
be amenable to more streamlined characterization in lower
organisms. The limitations of each model system (Table 2)
should be recognized in advance when deploying these
organisms for target validation. However, the ability to
perform ever-more detailed and mechanistic studies
indicates that such an approach should be productive.
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